RAFAEL HOLDINGS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value
RAFAEL HOLDINGS, INC. (RFL) had Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value of $1.85 per share as of 2025-10-31, per its 10-Q filed 2025-12-12.
Financial Statements › Notes › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsNonvestedWeightedAverageGrantDateFairValue · last filed 2025-12-12
- 2025-10-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $1.85.
- 2025-07-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $2.99; Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value as first filed $1.99.
- 2025-04-30: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $2.59.
- 2025-01-31: Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value $2.62.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value | Share-based Compensation Arrangement by Share-based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value as first filed |
|---|---|---|
| 2025-10-31 | $1.85 10-Q · filed 2025-12-12 | |
| 2025-07-31 | $2.99 10-Q · filed 2025-12-12 | $1.99 10-K · filed 2025-10-29 |
| 2025-04-30 | $2.59 10-Q · filed 2025-06-11 | |
| 2025-01-31 | $2.62 10-Q · filed 2025-03-14 | |
| 2024-10-31 | $3.02 10-Q · filed 2024-12-11 | |
| 2024-07-31 | $2.99 10-K · filed 2025-10-29 | |
| 2024-04-30 | $3.37 10-Q · filed 2024-06-14 | |
| 2024-01-31 | $3.36 10-Q · filed 2024-03-14 | |
| 2023-10-31 | $3.41 10-Q · filed 2023-12-14 | |
| 2023-07-31 | $4.04 10-K/A · filed 2024-12-20 | |
| 2023-04-30 | $3.82 10-Q · filed 2023-06-13 | |
| 2023-01-31 | $3.77 10-Q · filed 2023-03-14 | |
| 2022-10-31 | $4.22 10-Q · filed 2022-12-13 | |
| 2022-07-31 | $4.22 10-K/A · filed 2024-12-20 | |
| 2022-04-30 | $5.50 10-Q · filed 2022-06-14 | |
| 2022-01-31 | $23.68 10-Q · filed 2022-03-17 | |
| 2021-10-31 | $47.39 10-Q/A · filed 2022-02-28 | |
| 2021-07-31 | $46.77 10-K · filed 2023-10-30 | |
| 2021-04-30 | $15.28 10-Q · filed 2021-06-14 | |
| 2021-01-31 | $17.01 10-Q · filed 2021-03-17 | |
| 2020-10-31 | $13.79 10-Q · filed 2020-12-15 | |
| 2020-07-31 | $10.80 10-K · filed 2022-10-31 | |
| 2020-04-30 | $10.91 10-Q · filed 2020-06-09 | |
| 2020-01-31 | $11.91 10-Q · filed 2020-03-05 | |
| 2019-10-31 | $11.41 10-Q · filed 2019-12-09 | |
| 2019-07-31 | $10.41 10-K · filed 2021-10-18 | |
| 2019-04-30 | $10.62 10-Q · filed 2019-06-05 | |
| 2019-01-31 | $9.42 10-Q · filed 2019-03-12 | |
| 2018-10-31 | $4.90 10-Q · filed 2018-12-10 | |
| 2018-07-31 | $4.90 10-K · filed 2020-10-29 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Aditxt, Inc. (ADTX) | United States | $0.000B | |
| CDT Equity Inc. (CDT) | United States | $0.000B | -0.01 |
| Protagenic Therapeutics, Inc.\new (PTIX) | United States | $0.001B | |
| Decoy Therapeutics Inc. (DCOY) | United States | $0.002B | -0.27 |
| Nexentis Technologies Inc. (NXTS) | $0.002B | ||
| ORAGENICS INC (OGEN) | United States | $0.002B | |
| JUPITER NEUROSCIENCES, INC. (JUNS) | United States | $0.002B | -0.02 |
| BioXcel Therapeutics, Inc. (BTAI) | United States | $0.002B | |
| ZyVersa Therapeutics, Inc. (ZVSA) | United States | $0.002B | |
| Matinas BioPharma Holdings, Inc. (MTNB) | United States | $0.003B |